B. Riley Wealth Advisors’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2015
Q1
Sell
-3,050
Closed -$43 2353
2014
Q4
$43 Buy
+3,050
New +$43 ﹤0.01% 2174
2014
Q3
Sell
-1,500
Closed -$23.1K 2200
2014
Q2
$23.1K Sell
1,500
-4,850
-76% -$74.6K 0.01% 1407
2014
Q1
$108K Buy
6,350
+2,032
+47% +$34.6K 0.03% 596
2013
Q4
$56K Buy
+4,318
New +$56K 0.02% 652